ask="N/A"
ask_size="N/A"
average_daily_volume="54844"
bid="N/A"
bid_size="N/A"
book_value="1.19"
change="N/A"
change_from_200_day_moving_average="-1.31"
change_from_50_day_moving_average="-0.43"
change_from_52_week_high="-3.76"
change_From_52_week_low="0.20"
change_in_percent="N/A"
close="2.71"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.90"
ebitda="-15.74M"
eps_estimate_current_year="-3.71"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.81"
ex_dividend_date="N/A"
float_shares="5652000"
high="N/A"
high_52_weeks="6.47"
last_trade_date="2/13/2017"
last_trade_price="2.71"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="N/A"
low_52_weeks="2.51"
market_capitalization="17.06M"
moving_average_200_day="4.02"
moving_average_50_day="3.14"
name="MABVAX THERAPEUTICS"
notes="N/A"
one_year_target_price="18.00"
open="N/A"
pe_ratio="N/A"
peg_ratio="-0.01"
percent_change_from_200_day_moving_average="-32.65%"
percent_change_from_50_day_moving_average="-13.73%"
percent_change_from_52_week_high="-58.15%"
percent_change_from_52_week_low="+7.97%"
previous_close="2.71"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.27"
price_per_sales="18.84"
revenue="905615.00"
shares_outstanding="6296000"
short_ratio="7.82"
stock_exchange="NCM"
symbol="MBVX"
volume="0"
weeks_range_52="2.51 - 6.47"
